These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26081924)

  • 1. FOXM1 and its Oncogenic Signaling in Gastric Cancer.
    Wang H; Huang C
    Recent Pat Anticancer Drug Discov; 2015; 10(3):270-9. PubMed ID: 26081924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
    Wierstra I
    Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing forkhead box M1 promotes apoptosis and autophagy through SIRT7/mTOR/IGF2 pathway in gastric cancer cells.
    Yu W; Cui X; Wan Z; Yu Y; Liu X; Jin L
    J Cell Biochem; 2018 Nov; 119(11):9090-9098. PubMed ID: 29953672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1 in Cancer: Interactions and Vulnerabilities.
    Gartel AL
    Cancer Res; 2017 Jun; 77(12):3135-3139. PubMed ID: 28584182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1: From cancer initiation to progression and treatment.
    Koo CY; Muir KW; Lam EW
    Biochim Biophys Acta; 2012 Jan; 1819(1):28-37. PubMed ID: 21978825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting FOXM1 in cancer.
    Halasi M; Gartel AL
    Biochem Pharmacol; 2013 Mar; 85(5):644-652. PubMed ID: 23103567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development.
    Zhang Y; Ye X; Chen L; Wu Q; Gao Y; Li Y
    Int J Biol Sci; 2018; 14(5):531-541. PubMed ID: 29805304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression.
    Jiang W; Zhou F; Li N; Li Q; Wang L
    Int J Clin Exp Pathol; 2015; 8(6):6756-63. PubMed ID: 26261559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370.
    Feng Y; Wang L; Zeng J; Shen L; Liang X; Yu H; Liu S; Liu Z; Sun Y; Li W; Chen C; Jia J
    Mol Cancer Res; 2013 Aug; 11(8):834-44. PubMed ID: 23576572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1.
    Wu J; Qin W; Wang Y; Sadik A; Liu J; Wang Y; Song P; Wang X; Sun K; Zeng J; Wang L
    J Cell Biochem; 2018 Nov; 119(11):9042-9054. PubMed ID: 30076647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Her-2 upregulates FoxM1 in gastric cancer.
    Qi W; Li X; Zhang Y; Yao R; Qiu W; Tang D; Liang J
    Int J Mol Med; 2014 Jun; 33(6):1531-8. PubMed ID: 24715000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight correlation between FoxM1 and FoxP3+ Tregs in gastric cancer and their clinical significance.
    Li X; Ma K; Song S; Shen F; Kuang T; Zhu Y; Liu Z
    Clin Exp Med; 2018 Aug; 18(3):413-420. PubMed ID: 29804142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells.
    Miao L; Xiong X; Lin Y; Cheng Y; Lu J; Zhang J; Cheng N
    Cancer Genet; 2014 Mar; 207(3):75-82. PubMed ID: 24726291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness.
    Li Z; Jia Z; Gao Y; Xie D; Wei D; Cui J; Mishra L; Huang S; Zhang Y; Xie K
    Clin Cancer Res; 2015 Feb; 21(4):844-53. PubMed ID: 25501129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
    Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
    Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxM1 as a novel therapeutic target for cancer drug therapy.
    Xu XS; Miao RC; Wan Y; Zhang LQ; Qu K; Liu C
    Asian Pac J Cancer Prev; 2015; 16(1):23-9. PubMed ID: 25640357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOX(M1) news--it is cancer.
    Halasi M; Gartel AL
    Mol Cancer Ther; 2013 Mar; 12(3):245-54. PubMed ID: 23443798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1.
    Zeng J; Wang L; Li Q; Li W; Björkholm M; Jia J; Xu D
    J Pathol; 2009 Aug; 218(4):419-27. PubMed ID: 19235838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO-specific protease 6 promotes gastric cancer cell growth via deSUMOylation of FoxM1.
    Song JG; Xie HH; Li N; Wu K; Qiu JG; Shen DM; Huang CJ
    Tumour Biol; 2015 Dec; 36(12):9865-71. PubMed ID: 26164001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.